[EN] PYRROLO[3,2-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF [FR] DERIVES DE PYRROLO[3,2-C]PYRIDINE ET LEURS PROCEDES DE PREPARATION
[EN] PYRROLO[3,2-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF [FR] DERIVES DE PYRROLO[3,2-C]PYRIDINE ET LEURS PROCEDES DE PREPARATION
Pyrrolo[3,2-C]Pyridine Deriatives and Processes for the Preparation Thereof
申请人:Kim Jae-Gyu
公开号:US20070249658A1
公开(公告)日:2007-10-25
The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof
申请人:YUHAN Corporation
公开号:US07541366B2
公开(公告)日:2009-06-02
The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
PYRROLO[3,2-C]PYRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
申请人:Yuhan Corporation
公开号:EP1805177B1
公开(公告)日:2010-04-28
US7541366B2
申请人:——
公开号:US7541366B2
公开(公告)日:2009-06-02
[EN] A COMPOSITION FOR TREATING OR PREVENTING A CANCER COMPRISING PYRROLOPYRIDINE DERIVATIVES<br/>[FR] COMPOSITION COMPRENANT DES DÉRIVÉS DE LA PYRROLOPYRIDINE POUR LE TRAITEMENT OU LA PRÉVENTION D'UN CANCER
申请人:YUHAN CORP
公开号:WO2007001139A1
公开(公告)日:2007-01-04
[EN] The present invention provides a composition for treating or preventing a cancer comprising a pyrrolopyridine derivative or its salt and a pharmaceutically acceptable carrier. [FR] La présente invention concerne une composition qui est destinée à traiter ou à prévenir un cancer et qui comprend un dérivé de la pyrrolopyridine ou son sel ainsi qu'un vecteur pharmaceutiquement acceptable.